AGN vs PHX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

AGN

ARGENICA FPO [AGN]

45LOW

PHX

PHARMX FPO [PHX]

42LOW

Score Breakdown

AGN PHX
Technical
48
57
Catalyst
50
51
Sentiment
50
50
Fundamental
34
66
Momentum
22
55
Risk Gate
42
50

Key Metrics

AGN Metric PHX
$18.0MMarket Cap$79.1M
502KAvg Volume (20d)448K
N/AShort InterestN/A
$0.77052-Week High$0.200
$0.08752-Week Low$0.084
+0.0%Daily Change+0.0%
$0.140Reference Price$0.120
-117.8%ROE-5.9%
N/AProfit Margin-12.2%

Active Signals

AGN Signals

●MACD momentum is picking up steam
●Stochastic is stretched into overbought — could need a breather
●Pressing against the upper Bollinger Band — extended and may need to cool off
●On a tear — up 33.3% over the last 5 days
●Beating the Small Ords index — relative strength of 1.37, so it's outpacing the pack
●Volume-price trend suggests distribution — sellers may be sneaking out while price holds
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk

PHX Signals

●Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Moderate P/S ratio (10.3x)
●Small-cap ($20-100M)
●Capital raise activity (1 events)
●CANSLIM S: Tight float (41%)
●Negative profit margins (-12%)

Ask Scout AI to compare AGN and PHX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AGN vs PYC →AGN vs RHY →AGN vs TRI →AHC vs ALC →AHC vs ATX →
AGN Full Analysis → PHX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).